» Articles » PMID: 24592382

Enhanced Neural Cell Adhesion and Neurite Outgrowth on Graphene-based Biomimetic Substrates

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2014 Mar 5
PMID 24592382
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Neural cell adhesion and neurite outgrowth were examined on graphene-based biomimetic substrates. The biocompatibility of carbon nanomaterials such as graphene and carbon nanotubes (CNTs), that is, single-walled and multiwalled CNTs, against pheochromocytoma-derived PC-12 neural cells was also evaluated by quantifying metabolic activity (with WST-8 assay), intracellular oxidative stress (with ROS assay), and membrane integrity (with LDH assay). Graphene films were grown by using chemical vapor deposition and were then coated onto glass coverslips by using the scooping method. Graphene sheets were patterned on SiO2/Si substrates by using photolithography and were then covered with serum for a neural cell culture. Both types of CNTs induced significant dose-dependent decreases in the viability of PC-12 cells, whereas graphene exerted adverse effects on the neural cells just at over 62.5 ppm. This result implies that graphene and CNTs, even though they were the same carbon-based nanomaterials, show differential influences on neural cells. Furthermore, graphene-coated or graphene-patterned substrates were shown to substantially enhance the adhesion and neurite outgrowth of PC-12 cells. These results suggest that graphene-based substrates as biomimetic cues have good biocompatibility as well as a unique surface property that can enhance the neural cells, which would open up enormous opportunities in neural regeneration and nanomedicine.

Citing Articles

Adverse Effects of Non-Metallic Nanoparticles in the Central Nervous System.

Sikorska K, Sawicki K, Czajka M, Kapka-Skrzypczak L, Kruszewski M, Brzoska K Materials (Basel). 2023; 16(23).

PMID: 38068008 PMC: 10707257. DOI: 10.3390/ma16237264.


Fabricating a low-temperature synthesized graphene-cellulose acetate-sodium alginate scaffold for the generation of ovarian cancer spheriod and its drug assessment.

Suryavanshi P, Kudtarkar Y, Chaudhari M, Bodas D Nanoscale Adv. 2023; 5(18):5045-5053.

PMID: 37705775 PMC: 10496900. DOI: 10.1039/d3na00420a.


The mechanical, optical, and thermal properties of graphene influencing its pre-clinical use in treating neurological diseases.

Ye T, Yang Y, Bai J, Wu F, Zhang L, Meng L Front Neurosci. 2023; 17:1162493.

PMID: 37360172 PMC: 10288862. DOI: 10.3389/fnins.2023.1162493.


Graphene-Related Nanomaterials for Biomedical Applications.

Lazar A, Aghasoleimani K, Semertsidou A, Vyas J, Rosca A, Ficai D Nanomaterials (Basel). 2023; 13(6).

PMID: 36985986 PMC: 10051126. DOI: 10.3390/nano13061092.


Ultrasonication effects on graphene composites in neural cell cultures.

Dybowska-Sarapuk L, Sosnowicz W, Grzeczkowicz A, Krzeminski J, Jakubowska M Front Mol Neurosci. 2022; 15:992494.

PMID: 36187345 PMC: 9523217. DOI: 10.3389/fnmol.2022.992494.


References
1.
Li N, Zhang X, Song Q, Su R, Zhang Q, Kong T . The promotion of neurite sprouting and outgrowth of mouse hippocampal cells in culture by graphene substrates. Biomaterials. 2011; 32(35):9374-82. DOI: 10.1016/j.biomaterials.2011.08.065. View

2.
Belyanskaya L, Weigel S, Hirsch C, Tobler U, Krug H, Wick P . Effects of carbon nanotubes on primary neurons and glial cells. Neurotoxicology. 2009; 30(4):702-11. DOI: 10.1016/j.neuro.2009.05.005. View

3.
Feng L, Wu L, Qu X . New horizons for diagnostics and therapeutic applications of graphene and graphene oxide. Adv Mater. 2012; 25(2):168-86. DOI: 10.1002/adma.201203229. View

4.
Xia T, Kovochich M, Brant J, Hotze M, Sempf J, Oberley T . Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett. 2006; 6(8):1794-807. DOI: 10.1021/nl061025k. View

5.
Yang W, Lee J, Hong S, Lee J, Lee J, Han D . Difference between Toxicities of Iron Oxide Magnetic Nanoparticles with Various Surface-Functional Groups against Human Normal Fibroblasts and Fibrosarcoma Cells. Materials (Basel). 2017; 6(10):4689-4706. PMC: 5452863. DOI: 10.3390/ma6104689. View